BioSpace News Archive

Job Trends

New Janssen Initiative Aims to Advance Equitable Care and Address Hidden Threat of Amputation Related to Peripheral Artery Disease (PAD)

The Janssen Pharmaceutical Companies of Johnson & Johnson announced the launch of Save Legs.

March 31, 2022
·
11 min read
Business

UW Oshkosh Partners with Fauna Bio to Search for New Treatments for Human Disease

Fauna Bio, a biotechnology company pioneering the fields of comparative, computational and translational genomics, announced a partnership with the University of Wisconsin OshKosh to accelerate the translation of human therapeutics discovered through research into extreme mammal adaptation.

March 31, 2022
·
4 min read
Business

Cipherome, Inc. Joins Innovators’ Network at American Heart Association Center for Health Technology & Innovation

Cipherome, Inc. (“Cipherome”), a Silicon Valley-based, genomic bioinformatics start-up, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network.

March 31, 2022
·
2 min read
Biotech Bay

Renegade.bio Announces Decision to Continue No-Cost COVID-19 Testing for Symptomatic, Uninsured Bay Area Community

Renegade.bio Announces Decision to Continue No-Cost COVID-19 Testing for Symptomatic, Uninsured Bay Area Community.

March 31, 2022
·
2 min read
Drug Development

Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau®

Evolus Announces First Patient Enrolled in Phase II Clinical Study Evaluating “Extra-Strength” Dose of Jeuveau.

March 31, 2022
·
5 min read
Pharm Country

Marinus Pharmaceuticals Bolsters Financial Position With Drawdown of $30 Million Under Oaktree Capital Credit Facility

Marinus Pharmaceuticals , Inc. today announced it has received $30 million in funding under the existing Oaktree Capital Management, L.P. (Oaktree) credit agreement.

March 31, 2022
·
5 min read
Deals

Acer Therapeutics Regains Compliance with Nasdaq Listing Standard

Acer Therapeutics Inc. today announced that it has received notice from The Nasdaq Stock Market (Nasdaq) on March 30, 2022 informing Acer that it has regained compliance with the minimum market value of listed securities standard under Nasdaq List Standard.

March 31, 2022
·
1 min read
Business

Celsion Corporation Reports 2021 Financial Results and Provides Business Update

Celsion Corporation today announced financial results for the year ended December 31, 2021, and provided an update.

March 31, 2022
·
21 min read
Genetown

Biomodex® Announces Launch of Clear Cartridges for Neurovascular Training

Biomodex® today announced the launch of Clear Cartridges for use with all Biomodex EVIAS ™ and EVIAS Plus ™ stations.

March 31, 2022
·
2 min read
Business

Adagene Reports Full Year 2021 Financial Results and Provides Corporate Update

Adagene Inc. (“Adagene”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today reported financial results for the full-year ended December 31, 2021, and provided corporate updates.

March 31, 2022
·
23 min read